To further characterize the effect of SLC39A7 in glioma cells, we selected the U87 and LN229 cell lines for the overexpression of SLC39A7 since these cell lines had the lowest expression of SLC39A7 among all of the available cell lines (Fig. 2f, g). The gene discussed is SLC39A7; the disease is central nervous system cancer.